Tag: Levothyroxine recall

Affecting millions with hypothyroidism, the stability of levothyroxine is critical for patient health. A primary reason for recent instances where patients asked, 'Why was there a recall on levothyroxine?' relates to the medication's sensitive nature, which can cause its active ingredient to degrade over time, a problem known as subpotency.

In July 2025, the U.S. Food and Drug Administration (FDA) upgraded a significant recall involving more than 160,000 bottles of Levothyroxine Sodium, clarifying the answer to the question, "**What thyroid medicine is being recalled?**". This was classified as a Class II recall, indicating the product may cause temporary or medically reversible adverse health consequences.